Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 12 865 / https://doi.org/10.3332/ecancer.2018.865

Special Issue

Colorectal carcinogenesis: an archetype of gut microbiota–host interaction

Sporadic colorectal cancer (CRC) remains a major cause of worldwide mortality. Epidemiological evidence of markedly increased risk in populations that migrate to Western countries, or adopt their lifestyle, suggests that CRC is a disease whose aetiology is defined primarily by interactions between the host and his environment. The gut microbiome sits directly at this interface and is now increasingly recognised as a modulator of colorectal carcinogenesis. Bacteria such as Fusobacterium nucleatum and Escherichia coli (E. Coli) are found in abundance in patients with CRC and have been shown in experimental studies to promote neoplasia. A whole armamentarium of bacteriaderived oncogenic mechanisms has been defined, including the subversion of apoptosis and the production of genotoxins and pro-inflammatory factors. But the microbiota may also be protective: for example, they are implicated in the metabolism of dietary fibre to produce butyrate, a short chain fatty acid, which is anti-inflammatory and anti-carcinogenic. Indeed, although our understanding of this immensely complex, highly individualised and multi-faceted relationship is expanding rapidly, many questions remain: Can we define friends and foes, and drivers and passengers? What are the critical functions of the microbiota in the context of colorectal neoplasia?

Keywords: colorectal cancer, microbiota, fusobacterium, metabolic function, interaction

Loading Article Metrics ... Please wait

Related videos

Related articles

Case Report: Peliosis hepatis associated with follicular lymphoma with a rise in vascular endothelial growth factor and anaemia of inflammation

Abstract | Full Article | PDF | Spanish Published: 20 Nov 2018 / https://doi.org/10.3332/ecancer.2018.882

Short Communication: Learning from the past to design better trials in second-line treatment for mesothelioma patients

Abstract | Full Article | PDF Published: 08 Nov 2018 / https://doi.org/10.3332/ecancer.2018.881

Research: Information sources and online information seeking behaviours of cancer patients in Singapore

Abstract | Full Article | PDF Published: 31 Oct 2018 / https://doi.org/10.3332/ecancer.2018.880

Clinical Study: High tumour burden, delayed diagnosis and history of cardiovascular disease may be associated with carcinoid heart disease

Abstract | Full Article | PDF Published: 25 Oct 2018 / https://doi.org/10.3332/ecancer.2018.879

Research: Identifying barriers and finding solutions to implement best practices for cancer surgery at Maputo Central Hospital, Mozambique

Abstract | Full Article | PDF Published: 23 Oct 2018 / https://doi.org/10.3332/ecancer.2018.878



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation